Vitamin D status in chronic dialysis patients with depression: a prospective study

BMC Psychiatry

Jianghua Chen³  Jinfeng Duan⁵  Min Ni¹  Yongyao Wu²  Congyang Huang⁶  Beiyan Bao⁶  Xiaoying Ni⁴  Ping Zhang³  Jisheng Zhang² 

[1] Department of Psychiatry, Beilun Branch of the First Affiliated Hospital, College of Medicine, Zhejiang University, Ningbo, Zhejiang, PR China;Department of Nephrology, Beilun Branch of the First Affiliated Hospital, College of Medicine, Zhejiang University, Ningbo, Zhejiang, PR China;Department of Nephrology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China;Department of Neurology, People's Hospital of Yinzhou, College of Medicine, Ningbo University, Ningbo, Zhejiang, PR China;Department of Psychiatry, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China;Department of Nephrology, Ningbo Urology and Nephrology Hospital, College of Medicine, Ningbo University, Ningbo, Zhejiang, PR China

关键词: Prospective study;    Efficacy;    Dialysis;    End-stage renal disease;    Vitamin D;    Depression;   

Others  :  1123615
DOI  :  10.1186/1471-244X-14-125

 received in 2014-01-23, accepted in 2014-04-22,  发布年份 2014

【 摘 要 】

Background

Depression is the most widely acknowledged psychological problem among end-stage renal disease (ESRD) patients. Depression may be associated with VD deficiency. The aims of this study are to (a) elucidate the prospective association between HsCRP, VD contents and depressive symptoms in the dialyzed population, and (b) find the effect of calcitriol supplementation on depression in dialyzed patients.

Methods

In this prospective study, 484 dialysis patients (382 hemodialysis [HD] cases and 102 peritoneal dialysis [PD] cases; aged 18–60 years) from two hospitals in southeast China were included. The depression in these patients was evaluated using the Chinese version of Beck’s Depression Inventory (BDI). All subjects answered the BDI-I questionnaire for assessment of depression levels in summer. A cut-off value of 16 was set to include dialysis patients with depression. All patients were divided into two groups depending on the absence (Group1) or presence (Group 2) of depression. The two groups took 0.5 μg/day 1,25-Dihydroxyvitamin D orally for one year. BDI Scores were recalculated for all patients. Sociodemographic, clinical data, and serum VD contents were also collected.

Results

A total of 484 participants (247 men [51.0%] and 237 women [49.0%]) were surveyed. Depressive symptoms were found in 213 (44.0%) patients. The baseline serum VD level (VD2 + VD3) was 17.6 ± 7.7 nmol/L. Patients with depressive symptoms have significantly higher serum HsCRP level and significantly lower serum VD level compared with the control group. After one-year follow-up, the supplementation of 0.5 μg/day calcitriol slightly improved the microinflammatory state such as lowering mean serum HsCRP level and improving serum VD level, but not in significantly enhancing the depressive symptoms.

Conclusions

Calcitriol supplementation did not significantly enhance the depressive symptoms in our dialyzed population although patients with low levels of serum VD were more depressed. Therefore, more prospective randomized controlled trials are necessary to reveal the exact cause-and-effect relationship between VD status and depressive symptoms or VD status related to some specific subtypes in dialyzed patients.

【 授权许可】

   
2014 Zhang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Ibrahim N, Chiew-Thong NK, Desa A, Razali R: Depression and coping in adults undergoing dialysis for end-stage renal disease. Asia-Pacific Psychiatry 2013, 5(Suppl 1):35-40.
• [2]McKercher C, Sanderson K, Jose MD: Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy. Nephrology (Carlton, Vic) 2013, 18(9):585-591.
• [3]Park HC, Lee H, Lee JP, Kim DK, Oh KH, Joo KW, Lim CS, Kim YS, Ahn C, Oh YK: Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patients. J Korean Med Sci 2012, 27(1):64-71.
• [4]Hung AM, Ikizler TA, Griffin MR, Glenn K, Greevy RA, Grijalva CG, Siew ED, Crawford DC: CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey. BMC Med Genet 2011, 12:65.
• [5]Hung AM, Crawford DC, Griffin MR, Brown-Gentry K, Lipkowitz MS, Siew ED, Cavanaugh K, Lewis JB, Ikizler TA: CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol 2010, 5(1):24-33.
• [6]Li ZJ, An X, Mao HP, Wei X, Chen JH, Yang X, Zhou SF, Li ZB, Yu XQ: Association between depression and malnutrition-inflammation complex syndrome in patients with continuous ambulatory peritoneal dialysis. Int Urol Nephrol 2011, 43(3):875-882.
• [7]Czira ME, Lindner AV, Szeifert L, Molnar MZ, Fornadi K, Kelemen A, Laszlo G, Mucsi I, Keszei AP, Kennedy SH, Novak M: Association between the Malnutrition-Inflammation Score and depressive symptoms in kidney transplanted patients. Gen Hosp Psychiatry 2011, 33(2):157-165.
• [8]Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B: Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6. Kidney international. Supplement 2002, 80:103-108.
• [9]Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ: Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry 2012, 71(1):15-21.
• [10]Hoang MT, Defina LF, Willis BL, Leonard DS, Weiner MF, Brown ES: Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 2011, 86(11):1050-1055.
• [11]Brouwer-Brolsma EM, Feskens EJ, Steegenga WT, de Groot LC: Associations of 25-hydroxyvitamin D with fasting glucose, fasting insulin, dementia and depression in European elderly: the SENECA study. Eur J Nutr 2013, 52(3):917-925.
• [12]Tolppanen AM, Sayers A, Fraser WD, Lewis G, Zammit S, Lawlor DA: The association of serum 25-hydroxyvitamin D3 and D2 with depressive symptoms in childhood–a prospective cohort study. J Child Psychol Psychiatry 2012, 53(7):757-766.
• [13]Singer RF: Vitamin D, in dialysis: defining deficiency and rationale for supplementation. Semin Dial 2013, 26(1):40-46.
• [14]Duranton F, Rodriguez-Ortiz ME, Duny Y, Rodriguez M, Daures JP, Argiles A: Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol 2013, 37(3):239-248.
• [15]Metzger M, Houillier P, Gauci C, Haymann JP, Flamant M, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Ureña-Torres P: Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold. J Clin Endocrinol Metab 2013, 98(7):2922-2928.
• [16]Bruchas RR, de Las FL, Carney RM, Reagan JL, Bernal-Mizrachi C, Riek AE, Gu CC, Bierhals A, Schootman M, Malmstrom TK, Burroughs TE, Stein PK, Miller DK, Dávila-Román VG: The St. Louis African American health-heart study: methodology for the study of cardiovascular disease and depression in young-old African Americans. BMC Cardiovasc Disord 2013, 13:66. BioMed Central Full Text
• [17]Craven JL, Rodin GM, Littlefield C: The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med 1988, 18(4):365-374.
• [18]Yeung A, Howarth S, Chan R, Sonawalla S, Nierenberg AA, Fava M: Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care. J Nerv Ment Dis 2002, 190(2):94-99.
• [19]Shek DT: Depressive symptoms in alpha sample of chinese adolescents: an empirical study using the Chinese version of the beck depression inventory. Int J Adolesc Med Health 1992, 5(1):1-16.
• [20]Zhang J, Huang C, Li Y, Chen J, Shen F, Yao Q, Qian J, Bao B, Yao X: Health-related quality of life in dialysis patients with constipation: a cross-sectional study. Patient Prefer Adherence 2013, 7:589-594.
• [21]Sezer S, Uyar ME, Bal Z, Tutal E, Ozdemir AFN: The influence of socioeconomic factors on depression in maintenance hemodialysis patients and their caregivers. Clin Nephrol 2013, 80(11):342-348.
• [22]Nowak L, Adamczak M, Wiecek A: Is inflammation a new risk factor of depression in haemodialysis patients. Int Urol Nephrol 2013, 45(4):1121-1128.
• [23]Wu PC, Huang TW: Gender-related invariance of the Beck Depression Inventory II for Taiwanese adolescent samples. Assessment 2012, 2012:2012.
• [24]Appelhans BM, Whited MC, Schneider KL, Ma Y, Oleski JL, Merriam PA, Waring ME, Olendzki BC, Mann DM, Ockene IS, Pagoto SL: Depression severity, diet quality, and physical activity in women with obesity and depression. J Acad Nutr Diet 2012, 112(5):693-698.
• [25]Klumpp H, Post D, Angstadt M, Fitzgerald DA, Phan KL: Anterior cingulate cortex and insula response during indirect and direct processing of emotional faces in generalized social anxiety disorder. Biol Mood Anxiety Disord 2013, 3(1):7. BioMed Central Full Text
• [26]Rebollo P, Ortega F, Baltar JM, Badía X, Alvarez-Ude F, Díaz-Corte C, Naves M, Navascúes RA, Ureña A, Alvarez-Grande J: Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant 2000, 14(3):199-207.
• [27]Zhang F, Nunes M, Segmuller B, Dunphy R, Hesse RH, Setty SK: Degradation chemistry of a Vitamin D analogue (ecalcidene) investigated by HPLC-MS, HPLC-NMR and chemical derivatization. J Pharm Biomed Anal 2006, 40(4):850-863.
• [28]Jafri L, Khan AH, Siddiqui AA, Mushtaq S, Iqbal R, Ghani F, Siddiqui I: Comparison of high performance liquid chromatography, radio immunoassay and electrochemiluminescence immunoassay for quantification of serum 25 hydroxy vitamin D. Clin Biochem 2011, 44(10–11):864-868.
• [29]Snellman G, Melhus H, Gedeborg R, Olofsson S, Wolk A, Pedersen NL, Michaëlsson K: Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One 2009, 4(11):e7747.
• [30]Nabolsi MM, Wardam L, Al-Halabi JO: Quality of life, depression, adherence to treatment and illness perception of patients on haemodialysis. Int J Nurs Pract 2013. doi:10.1111/ijn.12205
• [31]Preljevic VT, Østhus TB, Os I, Sandvik L, Opjordsmoen S, Nordhus IH, Dammen T: Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patients. J Korean Med Sci 2012, 27(1):64-71.
• [32]Khalil AA, Frazier SK: Depressive symptoms and dietary nonadherence in patients with end-stage renal disease receiving hemodialysis: a review of quantitative evidence. Issues Ment Health Nurs 2010, 31(5):324-330.
• [33]Lew SQ, Piraino B: Quality of life and psychological issues in peritoneal dialysis patients. Semin Dial 2005, 18(2):119-123.
• [34]Ibrahim S, El SO: Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. Am J Nephrol 2008, 28(5):784-791.
• [35]Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, Mishima N: Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur J Clin Nutr 2009, 63(12):1444-1447.
• [36]Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X: Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord 2009, 118(1–3):240-243.
• [37]Brandenbarg J, Vrijkotte TG, Goedhart G, van Eijsden M: Maternal early-pregnancy vitamin D status is associated with maternal depressive symptoms in the Amsterdam Born Children and Their Development cohort. Psychosom Med 2012, 74(7):751-757.
• [38]Cassidy-Bushrow AE, Peters RM, Johnson DA, Li J, Rao DS: Vitamin D nutritional status and antenatal depressive symptoms in African American women. J Women’s Health 2012, 21(11):1189-1195.
• [39]Lee DM, Tajar A, O’Neill TW, O'Connor DB, Bartfai G, Boonen S, Bouillon R, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Wu FC, Pendleton N: Lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol (Oxford, England) 2011, 25(10):1320-1328.
• [40]Penckofer S, Kouba J, Byrn M, Estwing FC: Vitamin D and depression: where is all the sunshine. Issues Ment Health Nurs 2010, 31(6):385-393.
• [41]Kjaergaard M, Waterloo K, Wang CE, Almås B, Figenschau Y, Hutchinson MS, Svartberg J, Jorde R: Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case–control study and randomised clinical trial. Br J Psychiatry 2012, 201(5):360-368.
• [42]Bertone-Johnson ER, Powers SI, Spangler L, Larson J, Michael YL, Millen AE, Bueche MN, Salmoirago-Blotcher E, Wassertheil-Smoller S, Brunner RL, Ockene I, Ockene JK, Liu S, Manson JE: Vitamin D supplementation and depression in the women’s health initiative calcium and vitamin D trial. Am J Epidemiol 2012, 176(1):1-13.
• [43]Hogberg G, Gustafsson SA, Hallstrom T, Gustafsson T, Klawitter B, Petersson M: Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatrica (Oslo, Norway: 1992) 2012, 101(7):779-783.
• [44]Balsamo M, Imperatori C, Sergi MR, Belvederi Murri M, Continisio M, Tamburello A, Innamorati M, Saggino A: Cognitive vulnerabilities and depression in young adults: An ROC curves analysis. Depress Res Treat 2013, 2013:407602.
• [45]Pilz S, Gaksch M, O’Hartaigh B, Tomaschitz A, Marz W: The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013. Arch Toxicol 2013, 87(12):2083-2103.
• [46]Messa P, Curreri M, Regalia A, Alfieri CM: Vitamin D and the cardiovascular system: an overview of the recent literature. Am J Cardiovasc Drugs 2013, 14(1):1-14.